Citations

Showing 10 of 108073 citations.

Combination Systemic Therapies in Advanced Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs): A Comprehensive Review of Clinical Trials and Prospective Studies
Diamantopoulos, Leonidas Nikolaos , Kalligeros, Markos , Hálfdánarson, Þorvarður R. , Diamantis, Nikolaos , Toumpanakis, Christos , Diamantopoulos, Leonidas N , Halfdanarson, Thorvardur R

Mayo Clinic

Biology | July 31, 2023 | Volume: 12 | Issue: 8 | Pages: 1069

10.3390/biology12081069 | PMID 37626955 Get It

There is an evolving landscape of systemic combination regimens for patients with advanced well-differentiated gastroenteropancreatic neuroendocrine tumors (GEP-NETs). In this review, we provide a comprehensive outline of the existing clinical trials/prospective studies investigating these combinations. PubMed was searched using key relevant terms to identify articles referring to GEP-NETs and combination treatments. No systematic search of the literature or metanalysis of the data was performed, and we focused on the most recent literature results. Primarily, phase 1 and 2 clinical trials were available, with a smaller number of phase 3 trials, reporting results from combination treatments across a wide range of antiproliferative agents. We identified significant variability in the anti-tumor activity of the reported combinations, with occasional promising results, but only a very small number of practice-changing phase 3 clinical trials. Overall, the peptide receptor radionuclide therapy (PRRT)-based combinations (with chemotherapy, dual PPRT, and targeted agents) and anti-vascular endothelial growth factor (VEGF) agent combinations with standard chemotherapy were found to have favorable results and may be worth investigating in future, larger-scale trials. In contrast, the immune-checkpoint inhibitor-based combinations were found to have limited applicability in advanced, well-differentiated GEP-NETs.
Plasma‐derived biomarkers of Alzheimer's disease and neuropsychiatric symptoms: A community‐based study
Krell‐Roesch, Janina , Syrjanen, Jeremy A. , Kremers, Walter K. , Dage, Jeffrey L. , Fields, Julie A. , Petersen, Ronald C. , Vassilaki, Maria , Geda, Yonas E. , Zaniletti, Isabella, Geda, Yonas E , Kremers, Walter K , Dage, Jeffrey L , Zaniletti, Isabella , Algeciras‐Schimnich, Alicia , Harten, Argonde C. van , Knopman, David S. , Jack, Clifford R.

Mayo Clinic

Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring | July 31, 2023 | Volume: 15 | Issue: 3 | Pages: No page available

10.1002/dad2.12461 | PMID 37529120 Get It

AbstractINTRODUCTIONWe examined associations between plasma‐derived biomarkers of Alzheimer's disease (AD) and neuropsychiatric symptoms (NPS) in community‐dwelling older adults.METHODSCross‐sectional study involving 1005 persons ≥50 years of age (mean 74 years, 564 male, 118 cognitively impaired), who completed plasma‐derived biomarker (amyloid beta 42 [Aβ42]/Aβ40, phosphorylated tau 181 [p‐tau181], p‐tau217, total tau [t‐tau], neurofilament light [NfL]), and NPS assessment.RESULTSP‐tau181 (odds ratio [OR] 2.06, 95% confidence interval [CI] 1.41–3.00, p < 0.001), p‐tau217 (OR 1.70, 95% CI 1.10–2.61, p = 0.016), and t‐tau (OR 1.44, 95% CI 1.08–1.92, p = 0.012) were associated with appetite change. We also found that p‐tau181 and p‐tau217 were associated with increased symptoms of agitation (OR 1.93, 95% CI 1.20–3.11, p = 0.007 and OR 2.04, 95% CI 1.21–3.42, p = 0.007, respectively), and disinhibition (OR 2.39, 95% CI 1.45–3.93, p = 0.001 and OR 2.30, 95% CI 1.33–3.98, p = 0.003, respectively). Aβ42/Aβ40 and NfL were not associated with NPS.CONCLUSIONHigher plasma‐derived p‐tau181 and p‐tau217 levels are associated with increased symptoms of appetite change, agitation, and disinhibition. These findings may support the validity of plasma tau biomarkers for predicting behavioral symptoms that often accompany cognitive impairment.HIGHLIGHTS We studied 1005 community‐dwelling persons aged ≥ 50 years Higher plasma tau levels are associated with increased neuropsychiatric symptoms Aβ42/Aβ40 and NfL are not associated with neuropsychiatric symptoms Clinicians should treat neuropsychiatric symptoms in persons with high plasma‐derived tau
Artificial intelligence and digital pathology: clinical promise and deployment considerations
Zarella, Mark D. , McClintock, David S. , Batra, Harsh Vardhan , Gullapalli, Rama R. , Valante, Michael, Tan, V., Dayal, Shubham, Oh, Kei Shing , Lara, Haydee, Garcia, Chris, Abels, Esther, Gullapalli, Rama R , Garcia, Chris A

Mayo Clinic

Journal of Medical Imaging | July 30, 2023 | Volume: 10 | Issue: 05 | Pages: No page available

10.1117/1.jmi.10.5.051802 | PMID 37528811 Get It

A simulation workshop to introduce coping skills
Putnam, Elizabeth M. , Stratton, Kelcey J. , Lehrian, Laura E., Rochlen, Lauryn R. , Zisblatt, Lara

Mayo Clinic

The Clinical Teacher | July 30, 2023 | Volume: 20 | Issue: 6 | Pages: No page available

10.1111/tct.13607 | PMID 37518830 Get It

Abstract Background Experiencing clinical catastrophes can result in long‐lasting emotional and psychological impacts. In other fields, crisis simulation has been used to train professionals in coping skills. Approach Our workshop combined a simulated case with a clinical debrief and expert‐led teaching on coping skills. The ‘4Rs’ mnemonic, Recognise, Reflect, Reframe and Reach‐out, describes the key elements. This is grounded in social, cognitive and behavioural theories of stress and coping. Evaluation All 96 anesthesiology residents from one residency programme participated, in small groups, and a mixed methods analysis was used. The scenario was deemed stressful. The workshop introduced new techniques, with 72/87 (82.75%) reporting new coping skills in use at 1‐month follow‐up. For many residents, the descriptive language regarding their performance and abilities shifted from critical, negative self‐talk to positive and team‐focused immediately following the workshop. A striking finding from evaluations at all timepoints was that negative comments were typically self‐referencing whereas positive ones referenced colleague support and the team. Implications Combining stress exposure with formal exploration of emotional responses and coping skills teaching in this workshop was feasible, with benefits at 1‐month follow‐up. This laid the groundwork for a resilience curriculum and wider departmental interest in the topic of coping and stress responses.
O-065 Multicenter investigation into presentation, management and outcome of infectious intracranial aneurysms
Saad, Hassan , Newman, Sarah, Grossberg, Jonathan A , Cawley, C. Michael , Fox, C, Perez-Vaga, C, Burkhardt, Jan‐Karl , Salem, Mohamed M , Jabbour, Pascal , Starke, R, Lu, Victor M. , Levitt, M, Spiotta, Alejandro M , Alawieh, Ali , Dimisko, Laurie , Zohdy, Youssef M. , Pradilla, Gustavo , Jabbour, Pascal , Naamani, Kareem El , Schmidt, Richard F. , Gooch, Michael Reid , Abdelsalam, Ahmed , Levitt, M, Hertzberg, Vicki , Barrow, Daniel L. , Howard, Brian M

Mayo Clinic

SNIS 20th annual meeting oral abstracts | July 30, 2023 | Volume: No volume available | Issue: No issue available | Pages: A51.1-A51

10.1136/jnis-2023-snis.65 Get It

E-262 Pipeline embolization device for the treatment of unruptured intracranial saccular aneurysms: a systematic review and meta-analysis of long-term outcomes
Ghaith, Ahmed , Bydon, Mohamad , Ghaith, A, Ríos-Zermeño, Jorge , Greco, E, Tawk, Rabih G.

Mayo Clinic

SNIS 20th annual meeting electronic poster abstracts | July 30, 2023 | Volume: No volume available | Issue: No issue available | Pages: A234.2-A235

10.1136/jnis-2023-snis.361 Get It

O-034 Characterization of CSF-venous fistula venous drainage patterns and specific site of fistula origin: implications for transvenous embolization
Fermo, O, Huynh, Thien , Parizadeh, D

Mayo Clinic

SNIS 20th annual meeting oral abstracts | July 30, 2023 | Volume: No volume available | Issue: No issue available | Pages: A28.2-A29

10.1136/jnis-2023-snis.34 Get It

O-032 Transvenous embolization of cerebrospinal fluid-venous fistulas: long-term clinical and imaging outcomes
Fermo, O, Brewer, Kori L. , Parizadeh, D, Brewer, K, Huynh, Thien

Mayo Clinic

SNIS 20th annual meeting oral abstracts | July 30, 2023 | Volume: No volume available | Issue: No issue available | Pages: A27-A27

10.1136/jnis-2023-snis.32 Get It

P-028 Impact of the covid-19 pandemic on the intracranial aneurysm treatment and associated outcomes: a propensity score matching study
Ghaith, Ahmed , Nieves, Antonio Bon, Kashyap, Sonu , Bydon, Mohamad , Ghaith, A, Ghanem, M, Greco, E, Ríos-Zermeño, Jorge , Tawk, Rabih G.

Mayo Clinic

SNIS 20th annual meeting oral poster abstracts | July 30, 2023 | Volume: No volume available | Issue: No issue available | Pages: A74-A74

10.1136/jnis-2023-snis.100 Get It

E-092 Outcomes following surgical and endovascular treatment of extracranial vertebral artery aneurysms (VAA): a systematic evaluation of the literature
Ghaith, Ahmed , Akinnusotu, Oluwatoyin, Bhatti, Amjad N. , Jarrah, R, Bydon, Mohamad , Bendok, Bernard R. , Ghaith, A, Wahood, Waseem

Mayo Clinic

SNIS 20th annual meeting electronic poster abstracts | July 30, 2023 | Volume: No volume available | Issue: No issue available | Pages: A130.2-A130

10.1136/jnis-2023-snis.192 Get It